Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2003-10-02
2008-03-04
Chan, Christina (Department: 1644)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023200, C536S023500, C536S024330
Reexamination Certificate
active
07339038
ABSTRACT:
A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
REFERENCES:
patent: 4937747 (1990-06-01), Koller
patent: 5360735 (1994-11-01), Weinshank et al.
patent: 5362641 (1994-11-01), Fuks et al.
patent: 5571506 (1996-11-01), Regan et al.
patent: 5589604 (1996-12-01), Drohan et al.
patent: 5700671 (1997-12-01), Prieto et al.
patent: 5714345 (1998-02-01), Clark
patent: 5716817 (1998-02-01), Tornell
patent: 5799276 (1998-08-01), Komissarchik et al.
patent: 5799311 (1998-08-01), Agrawal et al.
patent: 5859929 (1999-01-01), Zhou et al.
patent: 6140552 (2000-10-01), Deboer et al.
patent: 6190875 (2001-02-01), Ben-Artzi et al.
patent: 6226792 (2001-05-01), Goiffon et al.
patent: 6230151 (2001-05-01), Agrawal et al.
patent: 6307965 (2001-10-01), Aggarwal et al.
patent: 6314420 (2001-11-01), Lang et al.
patent: 6426209 (2002-07-01), Ayal-Hershkovitz et al.
patent: 6475763 (2002-11-01), Ayal-Hershkovitz et al.
patent: 6664105 (2003-12-01), Pecker et al.
patent: 6800441 (2004-10-01), Pecker et al.
patent: 6946131 (2005-09-01), Peretz et al.
patent: 6960471 (2005-11-01), Pecker et al.
patent: 6986996 (2006-01-01), Pecker et al.
patent: 2001/0006630 (2001-07-01), Yacobi-Zeevi et al.
patent: 2002/0068061 (2002-06-01), Peretz et al.
patent: 2002/0088019 (2002-07-01), Yacoby-Zeevi
patent: 2002/0102560 (2002-08-01), Pecker et al.
patent: 2002/0114801 (2002-08-01), Pecker et al.
patent: 2002/0168749 (2002-11-01), Pecker et al.
patent: 2002/0194625 (2002-12-01), Zcharia et al.
patent: 2003/0031660 (2003-02-01), Yacobi-Zeevi et al.
patent: 2003/0068806 (2003-04-01), Ayal-Hershkovitz et al.
patent: 2003/0163836 (2003-08-01), Garofalo
patent: 2003/0170860 (2003-09-01), Pecker et al.
patent: 2003/0181687 (2003-09-01), Peretz et al.
patent: 2003/0190737 (2003-10-01), Pecker et al.
patent: 2003/0217375 (2003-11-01), Zcharia et al.
patent: 2004/0146497 (2004-07-01), Ilan et al.
patent: 2004/0146925 (2004-07-01), Pecker et al.
patent: 2004/0213789 (2004-10-01), Yacobi-Zeevi et al.
patent: 2005/0260187 (2005-11-01), Ilan et al.
patent: 2006/0008892 (2006-01-01), Yacobi-Zeevi et al.
patent: 735116 (2001-06-01), None
patent: 768820 (2004-08-01), None
patent: WO 92/01003 (1992-01-01), None
patent: WO 9504518 (1994-07-01), None
patent: WO 99/11798 (1999-03-01), None
patent: WO 99/18852 (1999-04-01), None
patent: WO 99/57153 (1999-11-01), None
patent: WO 00/03036 (2000-01-01), None
patent: WO 00/25817 (2000-05-01), None
patent: WO 02/19962 (2002-03-01), None
patent: WO 02/32283 (2002-04-01), None
patent: WO 2004/108065 (2004-12-01), None
Ngo et al. The Protein Folding Problem and Tertiary Structure Prediction. K. Merz, Jr. and S. Le Grand, Ed, Birkhauser Boston, 1994, pp. 491-495.
RT-PCR Methods & Applications Book 1. CLONOTECH Laboratories, Inc. 1991, First Edition, pp. 10-15, 26 and 40.
pET System Manual 6thEdition, NOVAGEN, Inc. Aug. 1995, p. 11.
Ennis et al. PNAS USA 87, pp. 2833-2837, 1990.
Goshen et al. “Purification and Characterization of Placental Heparanase and it: Expression by Cultured Cytotrophoblats”,Molecular Huiman Reproduction, 2(9): 679-684, 1996.
Bar-Ner et al, “Inhibition of Heparanase-Mediated Degradatin of Extracellular vlatrix Heparan Sulphate by Non-anticoagulant Heparin Species”,Blood, 70(2): 551-557, 1987.
Savitsky et al, “Ataxia-Telangicetasia: Structural Diversity of Untranslated Secuences Suggests Complex Post-Transcriptional Regulation ofATMGene Expression”,Nucleic, cids Research, 25(9): 1678-1684 , 1997.
Haimovitz-Friedman et al, “Activation of Platelet Heparitanase by Tumor Cell Derived Factors”,Blood, 78: 789-796, 1991.
Gospodarowicz et al, Stimulation of Corneal Endothelial Cell Proliferation in vitro by Fibroblast and Epidemal Growth Factors,Exp. Eye Res., 25: 75-89, 1977.
Ernst et al. “Enzymsatic degradation of Glycosaminoglycans”,Crit. Rev. In Biochem. &Molec. Biology, 30(5): 387-444, 1995.
Zhong-Sheng et al. “Role of Heparan Sulfate Proteoglycans in the Binding and Uptake of Apoliprotein E-enriched Remnant Lipoproteins by Cultured Cells”,J. Biol. Chem., 268(14): 10160-10167, 1993.
R Ross. “The Pathogenesis of Atheroscerosis: A Perspective for the 1990s”,Nature, 362: 801-809, 1993.
1993Putnak et al, “A Putative Cellular Receptor for Dengue Viruses”,Nature Medicine, 3(8): 828-829. 1997.
Cordon-Cardo et al. “Expression of Basic Fibroblast Growth Factor in Normal Human Tissues”,Laboratory Investigation, 63(6): 832-840, 1990.
Narindrasorasak et al, “High Affinity Interactions between the Alzheimer's β-Amy.oid Precursor Proteins and the Basement Membrane Form of Heparan Sulfate Proteoglycan”,J. Liol. Chem., 266(20): 12878-12883, 1991.
Chen et al, “Dengue Virus Infectivity Depends opn Envelope Proteion Bin to Targt Cell Heparan Sulfate”.Nature Medicine, 3(8): 866-871, 1997.
Shieh et al, “Cell Surface Receptors for Herpes Simplex Virus are Heparan Sulfate Proteoglycan Proteoglycans”,J. Cell Biol., 116(5): 1273-1281, 1992.
Eisenberg et al, “Liposprotein Lipase Enhances Binding of Lipoproteins to Heparan Sulfate on Cell Surfaces and Extracellular Matrix”,J. Clin. Invest., 90: 2013-2021, 1992.
Rapraeger et al, “Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation”,Science, 252: 1705-1708, 1991.
Lider et al, “A Disaccharide that Inhibits Tumor Necrosis Factor α is Formed fron the Extracellular Matrix by the Enzyme Heparanase”,Proc. Natl. Acad. Sci. USA, 92:5037-5041, 1595.
Lider et al. “Suppression of Experimental Autoimmune Diseases and Prolongation of Allograft Survival by Treatment of Animals with Low Doses of Heparins”,J. Clin. Invest., 83: 752-756, 1989.
Gitay-Goren et al, “The Binding of Vascular Endothelial Growth Factor to its Receptors is Dependent on Cell Surface-associated Heparin-like Molecules”,J. Biol. Chem., 267(9): 6093-6098, 1992.
Ornitz et al. “FGF Binding and FGF Receptor Activation by Synthetic Heparin Derived Di- and Trisaccharides”,Science, 268: 432-436, 1995.
Spivak-Kroizman et al, “Heparin-Induced Oligomerization of FGF Molecules is Responsible for FGF Receptor Dimerization, Activation, and Cell Proliferation”,Cell, 79: 1015-1024, 994.
Yayon et al, “Cell Surface. Heparin-Like Molecules are required for Binding of Basic Fibroblast Growth Factor to its High Affinity Receptor”,Cell, 64: 841-848, 1991.
Vlodavsky et al, “Extracellular Sequestration and release of Fibroblast Growth Fac or: A Regulatory Mechanism?”,Trends Biochem. Sci., 16: 268-271, 1991.
Ishai-Michaeli et al, “Heparanase Activity Expressed by Platelets, Neutrophils, and Lymphoma Cells releases Active Fibroblast Growth Factor from ExtraCellular Matrix”,Cell Regulation, 1: 833-842, 1990.
Ishai-Michaeli et al, “Importance of Size and Sulfatiuon of Heparin in Release of Basic Fibroblast Growth Factor from the Vascular Endothelium and ExtraCellular Matrix”,Biochemistry, 31(7): 2080-2088, 1992.
Folkman et al, “A Heparin-Binding Angiogenic Protein—Basic Fibroblast Growth Factor—is Stored Within Basement Membrane”,Am. J. Pathology, 130(2): 393-400, 1988.
Vlodavsky et al, “Endothelial Cell-Derived Basic Fibroblast Growth Factor: Synthesis and Deposition into Subendothelial ExtraCellular Matrixȁ
Friedmann Yael
Pecker Iris
Peretz Tuvia
Vlodavsky Israel
Hadasit Medical Research Services and Development Ltd.
InSight Biopharmaceuticals Ltd.
LandOfFree
Heparanase specific molecular probes and their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparanase specific molecular probes and their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparanase specific molecular probes and their use in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3981004